Inhibikase Therapeutics Inc
NASDAQ:IKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
US |
|
Mitsubishi HC Capital Inc
OTC:MIUFF
|
JP |
|
Cbrain A/S
F:C6F
|
DK |
|
H
|
HCA Healthcare Inc
F:2BH
|
US |
|
T
|
Teradyne Inc
F:TEY
|
US |
|
E
|
Erlebnis Akademie AG
SWB:EAD
|
DE |
|
Prosegur Compania de Seguridad SA
F:PRHA
|
ES |
|
Z
|
Ziprecruiter Inc
F:47R
|
US |
|
3
|
3M Co
XHAM:MMM
|
US |
|
Bank of Communications Co Ltd
F:C4C
|
CN |
|
O'Reilly Automotive Inc
NASDAQ:ORLY
|
US |
|
A
|
Accuray Inc
F:XEJ
|
US |
|
T
|
TUI AG
XMUN:TUI1
|
DE |
|
L
|
Lam Research Corp
XMUN:LAR
|
US |
|
Discovery Ltd
F:D3H
|
ZA |
Intrinsic Value
The intrinsic value for
Inhibikase Therapeutics Inc (IKT) under the Base Case is hidden
USD.
Compared with the current market price of 1.87 USD, the stock appears hidden
.
IKT looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether IKT usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Inhibikase Therapeutics Inc.
The intrinsic value for
Inhibikase Therapeutics Inc (IKT) under the Base Case is hidden USD.
Compared with the current market price of 1.87 USD, the stock appears hidden.